VIVO Cannabis Inc. (OTCMKTS:VVCIF) Enhancing Its Product Offerings As It Partners With Several Players

VIVO Cannabis Inc. (OTCMKTS:VVCIF) has offered an update of its operations in Canada, Australia, and Germany that have positioned it as a top provider of solutions in the healthcare sector.

The company’s CEO, Barry Fishman, indicated that the company’s top priority is globally focusing on the medical cannabis market. VIVO’s focus has been to serve patients and invest in product development operations that prioritize premium cannabis products. Fishman indicated that the company made significant progress in recent times in several key initiatives that will help the company in solidifying its presence as one of the providers of patient and healthcare solutions globally.

VIVO enters partnership through its subsidiaries

Recently the company entered a product supply and clinic services agreement with Medical Cannabis by shoppers. VIVO’s subsidiaries CannaFarms™ and Beacon Medical™, will offer branded medical marijuana products through the online sales platform of Medical Cannabis by Shoppers™ to patients in Canada. The products will also include cannabis derivatives such as extracts and chocolates.

Also, in Australia, the company’s subsidiary Beacon Medical Australia entered a supply deal with MediPharm labs Australia for the purchase of GMP certified cannabis products for the Australian market. The agreement requires MediPharm to supply GMP-certified THC and CBD oils to Beacon medical for distribution under the branding of Beacon Medical. Equally, the company signed a collaboration deal with Veterans House through which VIVO will offer support and sponsorship to joint programs for veterans of Canadian Armed Forces. The company, through Canna Farms, will support veterans through the provision of medical cannabis products.

Vivo enhancing product offering

Most importantly, the company continues to expand its product line, and it introduced soft gel capsules of different concentrations. The products will be available through the online medical marketplace of Canna Farms, and the capsule will provide patients with an effective way to ingest cannabis products in a dosed format. The unveiling of the capsule comes after the successful launch of cannabis derivatives that include extracts and chocolates. This has enhanced VIVO’s offering selection to its over 20,000 patients.